These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 21854760)
21. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer. Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804 [TBL] [Abstract][Full Text] [Related]
22. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400 [TBL] [Abstract][Full Text] [Related]
23. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760 [TBL] [Abstract][Full Text] [Related]
24. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942 [TBL] [Abstract][Full Text] [Related]
25. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Leu YW; Rahmatpanah F; Shi H; Wei SH; Liu JC; Yan PS; Huang TH Cancer Res; 2003 Oct; 63(19):6110-5. PubMed ID: 14559786 [TBL] [Abstract][Full Text] [Related]
26. DNMT3b -149C/T promoter variants and methylation of colorectal cancer-associated genes. Naghibalhossaini F; Mokarram P; Khalili E; Naghibalhossaini S Cancer Biomark; 2015; 15(3):227-33. PubMed ID: 25769449 [TBL] [Abstract][Full Text] [Related]
27. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894 [TBL] [Abstract][Full Text] [Related]
28. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Chang KP; Hao SP; Liu CT; Cheng MH; Chang YL; Lee YS; Wang TH; Tsai CN Oral Oncol; 2007 Apr; 43(4):345-51. PubMed ID: 16920385 [TBL] [Abstract][Full Text] [Related]
29. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Girault I; Tozlu S; Lidereau R; Bièche I Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514 [TBL] [Abstract][Full Text] [Related]
30. Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells. Pearce EG; Laxton RC; Pereira AC; Ye S Mol Cancer Res; 2007 Mar; 5(3):221-7. PubMed ID: 17339606 [TBL] [Abstract][Full Text] [Related]
31. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer. Wang SH; Liu NH; Wang J; Bai H; Mao L Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105 [TBL] [Abstract][Full Text] [Related]
32. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b. Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367 [TBL] [Abstract][Full Text] [Related]
33. XIST repression in the absence of DNMT1 and DNMT3B. Vasques LR; Stabellini R; Xue F; Tian XC; Soukoyan M; Pereira LV DNA Res; 2005; 12(5):373-8. PubMed ID: 16769694 [TBL] [Abstract][Full Text] [Related]
34. Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: a case-control study. Jaiswal SK; Sukla KK; Kumari N; Lakhotia AR; Kumar A; Rai AK Birth Defects Res A Clin Mol Teratol; 2015 Apr; 103(4):299-305. PubMed ID: 25656965 [TBL] [Abstract][Full Text] [Related]
35. DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Soejima K; Fang W; Rollins BJ Oncogene; 2003 Jul; 22(30):4723-33. PubMed ID: 12879017 [TBL] [Abstract][Full Text] [Related]
36. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225 [TBL] [Abstract][Full Text] [Related]
37. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283 [TBL] [Abstract][Full Text] [Related]
38. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer. Wang J; Walsh G; Liu DD; Lee JJ; Mao L Cancer Res; 2006 Sep; 66(17):8361-6. PubMed ID: 16951144 [TBL] [Abstract][Full Text] [Related]
39. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer. Zhang ML; Lu S; Zhou L; Zheng SS Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503 [TBL] [Abstract][Full Text] [Related]
40. Cell cycle-dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements. Tschöp K; Engeland K FEBS J; 2007 Oct; 274(20):5235-49. PubMed ID: 17868378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]